← feed

Is NCT03182257 results overdue?

Yes — results are overdue. Primary completion was 2018-01-30; the FDAAA-801 reporting deadline (2019-01-30) passed 2699 days ago and no results are posted on ClinicalTrials.gov.

Study of ONO-7579 in Patients With Advanced Solid Tumors/ NTRK Gene Fusion Positive Advanced Solid Tumors

NCT IDNCT03182257 ↗
SponsorOno Pharmaceutical Co., Ltd. (INDUSTRY)
PhasePHASE1
StatusTERMINATED
Primary completion2018-01-30 (ACTUAL)
Reporting deadline2019-01-30 (completion + 365d)
Days overdue2699
Results postedNo — check results tab ↗
FDA-regulateddrug: yes, device: no
ProvenanceFlagged overdue on 2026-06-21 · SHA-256 78cd426cc323c3d8… (hash-chained, tamper-evident)

Source of record: ClinicalTrials.gov NCT03182257. The reporting requirement is FDAAA 801 (Public Law 110-85 §801) and the Final Rule, 42 CFR Part 11.

⚠ Public-record facts from ClinicalTrials.gov — not a finding of violation, fraud, or non-compliance, and not legal or investment advice. Full disclaimer →